RAP-iDLD: Reducing Anxiety Problems Among Children Indicated to Have Developmental Language Disorder

Sponsor
Nanyang Technological University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05552365
Collaborator
(none)
42
1
2
10.6
4

Study Details

Study Description

Brief Summary

This study aims to pilot a world-first intervention, a mental health intervention augmented for children indicated with developmental language disorder (DLD). It serves as a proof-of-concept of how existing observational studies on these topics at the Centre for Research in Child Development (c.f. Tran-Sen; Gibber) can be translated into interventions. Mental health problems here are defined as anxiety type problems of social anxiety, specific phobia, separation anxiety and generalised anxiety. DLD is defined as a marked difficulty in oral language in the absence of biomedical causes (Bishop et al., 2017). This randomised pilot answers three uncertainties in preparation for a future definitive randomised control trial (RCT).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Adapted Cognitive Behavioural
  • Other: Treatment as Usual
N/A

Detailed Description

This pilot aims to answer three uncertainties for a future randomised control trial (RCT), namely (1) Is the proposed intervention's efficacy sufficient (2) Are the proposed methods of recruitment sufficient (3) Are the proposed measures of evaluation sufficient Hypotheses: (1) Piloted intervention is sufficient for definitive RCT as 90% confidence intervals contain expected improvement versus treatment-as-usual (2) Piloted recruitment methods are sufficient for definitive RCT as recruitment rate is >4/month, dropout rate<25%. (3) Piloted measures are sufficient for definitive RCT as rates of unusable data are <20% and reliability alpha

.70.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
42 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Masking Description:
The clinical interview (ADIS) will be administered by assessors who will not be told which arm participants are. Participants will be told not to mention intervention arm status to assessors.
Primary Purpose:
Prevention
Official Title:
Randomised Pilot Control Trial for Reducing Anxiety Problems Among Children Indicated to Have Developmental Language Disorder
Anticipated Study Start Date :
Dec 12, 2022
Anticipated Primary Completion Date :
Oct 31, 2023
Anticipated Study Completion Date :
Oct 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Active Intervention

8-session cognitive behavioural intervention adapted for children indicated to have developmental language disorder.

Behavioral: Adapted Cognitive Behavioural
8-session cognitive behavioural intervention adapted for children indicated to have developmental language disorder. Intervention includes psychoeducative, bodily relaxation, graded exposure, cognitive restructuring and brainstorming. Adaptations include increasing the number of visual supports, use of physical objects to illustrate concepts in addition to language.

Other: Treatment as Usual

Participants are re-directed to mental health support services. All participants given a mental health brochure which has contact details of mental health services for children.

Other: Treatment as Usual
Participants given a mental health brochure with contact information, where they can access services provided by mental health support service providers.

Outcome Measures

Primary Outcome Measures

  1. Anxiety Disorders Interview Schedule (ADIS-IV; Brown et al., 2004) [Administered at post treatment which is a maximum of 4 weeks from final session]

    The ADIS-IV is a semi-structured interview organised diagnostically to permit differential diagnoses of anxiety disorders. Its yields a severity rating (0 to 8) which is utilised here as the primary outcome

Secondary Outcome Measures

  1. Screen for child anxiety related emotional disorders (SCARED; Birmaher et al., 1999) [Administered at post treatment which is a maximum of 4 weeks from final session]

    The SCARED is a child and parent self-report instrument used to screen for childhood anxiety disorders including general anxiety disorder. The child report scores (41 items) and parent report scores (41 items) of the SCARED will be utilised here.

  2. Child Anxiety Life Interference Scale (CALIS; Lyneham, et. al., 2013) [Administered at post treatment which is a maximum of 4 weeks from final session]

    CALIS is a 2-part scale that measures child's anxiety life interference from both the child's and parent's perspectives. The children scale is a 10-item self-reported questionnaire on questionnaire evaluating the interference to the child's life and to the parent's life. All the items are related to common daily activities. The items are rated on a 5-point Likert scale (0 = Not at all, 1 = Only a little, 2 = Sometimes, 3 = Quite a lot, 4 = A great deal), where the higher scores indicate high levels of interference. Scores from the child and parent version will be used here

Other Outcome Measures

  1. Child Outcome and Session Rating Scales (CORS; Duncan et al., 2003) [At the end of each of the 8-sessions (each session is expected to run for 60 - 90 mins) for the active intervention]

    The CORS is targeted for children aged 6 to 12 and has the same format as the Outcome Rating Scales (Duncan et al.,2003). It is written in a child-friendly language, where the child uses the happy and sad faces to understand the scale (Duncan et al., 2003).

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Shows signs of elevated anxiety, fear or stress, as rated on anxiety measures conducted by this study

  • Enrolled in Primary 1 to 6 in a Ministry of Education Primary School

  • Signs of a language difficulty [Either one of the following]

  1. Existing clinical opinion/report of this when child >5 years old

  2. Score <10th percentile on language measures conducted by this study

Exclusion Criteria:
  • Conditions which exclude Developmental Language Disorder (e.g. Autism, Intellectual Disability, Hearing Impairment, other biomedical conditions).

  • Non-anxiety disorder as primary mental health disorder

  • Currently receiving treatment for anxiety disorder (e.g. pharmacotherapy or psychotherapy).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre for Research in Child Development, OER, NIE-NTU Singapore Singapore

Sponsors and Collaborators

  • Nanyang Technological University

Investigators

  • Principal Investigator: Shaun KY Goh, PhD, NTU-NIE

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Shaun Goh Kok Yew, Lecturer, Nanyang Technological University
ClinicalTrials.gov Identifier:
NCT05552365
Other Study ID Numbers:
  • RP 2/21 SG (2021-T1-001-011)
First Posted:
Sep 23, 2022
Last Update Posted:
Dec 6, 2022
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 6, 2022